Article PDF
Use our pre-submission checklist
Avoid common mistakes on your manuscript.
Rights and permissions
About this article
Cite this article
Front-line-Chemotherapie plus Bevacizumab verlängert das progressionsfreie Überleben. Best Practice Onkologie 5, 18 (2010). https://doi.org/10.1007/BF03359702
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03359702